Evidence map›Paper›PMID 41273694›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Micronucleus Assay with Tetrad Cells of Tradescantia.

Miroslav Mišík, Clemens Pichler, Bernhard Rainer, Armen Nersesyan, Katarína Mišíková, Franziska Ferk, Siegfried Knasmueller

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Miroslav MišíkCenter for Cancer Research, Medical University of Vienna, Vienna, Austria.
Clemens PichlerCenter for Cancer Research, Medical University of Vienna, Vienna, Austria.
Bernhard RainerCenter for Cancer Research, Medical University of Vienna, Vienna, Austria.
Armen NersesyanCenter for Cancer Research, Medical University of Vienna, Vienna, Austria.
Katarína MišíkováDepartment of Botany, Faculty of Natural Sciences, Comenius University of Bratislava, Bratislava, Slovakia.
Franziska FerkCenter for Cancer Research, Medical University of Vienna, Vienna, Austria.
Siegfried KnasmuellerCenter for Cancer Research, Medical University of Vienna, Vienna, Austria. siegfried.knasmueller@meduniwien.ac.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Tradescantia micronucleus assay has been used for 50 years for the detection of genotoxins (including carcinogens) in the environment. Micronuclei are extranuclear bodies that contain entire chromosomes or chromosomal fragments and can be scored under the microscope. A large database concerning the effects of individual chemicals and complex environmental mixtures (soil, air, water) has accumulated. In contrast to other mutagenicity test systems, the effects of low concentrations of heavy metals, radionuclides, certain herbicides and pesticides, and gaseous mutagens can be detected, and it is also possible to conduct in situ biomonitoring studies with the plant. The test system has been validated, and standardized protocols have been developed for laboratory experiments and for field studies, which are described in this chapter.

Indexed as

TradescantiaMicronucleus TestsMutagensMutagensGenotoxicity studiesMicronucleusTetradsTradescantia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.